Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biosimilars To Be Subject To Same Pay-For-Delay Deal Reporting As Generics
02 Oct 2018
•
By
Cathy Kelly
Legislation headed to President Trump would also ban pharmacy "gag" clauses.
More from Biosimilars
More from Biosimilars & Generics